Mylan Hit With Infringement Suit Over MS Generic Drug
Mylan has been using Momenta's patented manufacturing methods to make a generic version of a multiple sclerosis treatment, the Johnson & Johnson unit alleged in a new infringement lawsuit in Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article